Publikationen - Institut für Radiopharmazeutische Krebsforschung - Jahr 2016

Gesamtzahl lt. Auswahl: 19 Datensätze

19 Publikationen

2016

Targetting microglia activation in schizophrenia by minocycline treatment

Mattei, D.; Ivanov, A.; Ferrai, G.; Jordan, P.; Guneykaya, D.; et al. (16 authors)

European Neuropsychopharmacology 26(2016), 134

Evaluation of the enantiomer specific biokinetics and radiation doses of [18-F]-fluspidine – a new tracer in clinical translation for imaging of σ1 receptors

Kranz, M.; Sattler, B.; Wüst, N.; Deuther-Conrad, W.; Patt, M.; et al. (13 authors)

Molecules 21(2016), 1164
DOI: 10.3390/molecules21091164

Synthesis and evaluation of a 18F-labeled 4-phenylpiperidine-4-carbonitrile radioligand for σ1 receptor imaging

Ye, J.; Wang, X.; Deuther-Conrad, W.; Zhang, J.; Li, J.; et al. (10 authors)

Journal of Labelled Compounds and Radiopharmaceuticals (2016), 332-339
DOI: 10.1002/jlcr.3408

Tos-Nos-Mos: Synthesis of different aryl sulfonate precursors for the radiosynthesis of the alpha7 nicotinic acetylcholine receptor radioligand [¹⁸F]NS14490

Rötering, S.; Scheunemann, M.; Günther, R.; Löser, R.; Hiller, A.; et al. (9 authors)

Applied Radiation and Isotopes 114(2016), 57-62
DOI: 10.1016/j.apradiso.2016.04.028

Radiation dosimetry of the α4β2 nicotinic receptor ligand (+)-[¹⁸F]Flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results

Kranz, M.; Sattler, B.; Tiepolt, S.; Wilke, S.; Deuther-Conrad, W.; et al. (15 authors)

EJNMMI Physics (2016), 3-25
DOI: 10.1186/s40658-016-0160-5

Novel radioligands for cyclic nucleotide phosphodiesterase imaging with positron emission tomography: An update on developments since 2012

Schröder, S.; Wenzel, B.; Deuther-Conrad, W.; Scheunemann, M.; Brust, P.

Molecules 21(2016)5, 650
DOI: 10.3390/molecules21050650

Varying Chirality Across Nicotinic Acetylcholine Receptor Subtypes: Selective Binding of Quinuclidine Triazole Compounds

Sarasamkan, J.; Scheunemann, M.; Apaijai, N.; Palee, S.; Parichatikanond, W.; et al. (12 authors)

ACS Medicinal Chemistry Letters 7(2016)10, 890-895
DOI: 10.1021/acsmedchemlett.6b00146

Comparison of in silico, electrochemical, in vitro and in vivo metabolism of a homologous series of (radio)fluorinated sigma1 receptor ligands designed for positron emission tomography

Wiese, C.; Große Maestrup, E.; Galla, F.; Schepmann, D.; Hiller, A.; et al. (13 authors)

ChemMedChem 11(2016), 2445-2458
DOI: 10.1002/cmdc.201600366

Beta-Amyloid-PET-Bildgebung des Gehirns - DGN-Handlungsempfehlung

Barthel, H.; Meyer, P. T.; Drzezga, A.; Bartenstein, P.; Boecker, H.; et al. (17 authors)

Nuklearmedizin 55(2016)4, 129-137
DOI: 10.3413/Nukmed-0816-16-04

99mTc-Cyclopentadienyl Tricarbonyl Chelate-Labeled Compounds as Selective Sigma‑2 Receptor Ligands for Tumor Imaging

Li, D.; Chen, Y.; Wang, X.; Deuther-Conrad, W.; Chen, X.; et al. (11 authors)

Journal of Medicinal Chemistry 59(2016)3, 934-946
DOI: 10.1021/acs.jmedchem.5b01378

LC-MS supported Studies on the in vitro Metabolism of both Enantiomers of Flubatine and the in vivo Metabolism of (+)-[18F]Flubatine – a Positron Emission Tomography Radioligand for Imaging α4β2-Nicotinic Acetylcholine Receptors

Ludwig, F.-A.; Smits, R.; Fischer, S.; Donat, C. K.; Hoepping, A.; et al. (7 authors)Brust, P.; Steinbach, J.

Molecules 21(2016)9, 1200
DOI: 10.3390/molecules21091200

Thyroid hormone status defines brown adipose tissue activity and browning of white adipose tissues in mice

Weiner, J.; Kranz, M.; Klöting, N.; Kunath, A.; Steinhoff, K.; et al. (20 authors)

Scientific Reports 6(2016), 38124
DOI: 10.1038/srep38124

Changes in Binding of [123I]CLINDE, a High-Affinity Translocator Protein 18 kDa (TSPO) Selective Radioligand in a Rat Model of Traumatic Brain Injury

Donat, C. K.; Gaber, K.; Meixensberger, J.; Brust, P.; Pinborg, L. H.; et al. (7 authors)Hansen, H. H.; Mikkelsen, J. D.

Neuromolecular Medicine 18(2016)2, 158-169
DOI: 10.1007/s12017-016-8385-y

Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor

Moldovan, R.-P.; Teodoro, R.; Deuther-Conrad, W.; Kranz, M.; Wang, Y.; et al. (13 authors)

Journal of Medicinal Chemistry 59(2016)17, 7840-7855
DOI: 10.1021/acs.jmedchem.6b00554

Development of a new radiofluorinated quinoline analog for PET imaging of phosphodiesterase 5 (PDE5) in brain.

Liu, J.; Wenzel, B.; Dukic-Stefanovic, S.; Teodoro, R.; Ludwig, F.-A.; et al. (11 authors)

Pharmaceuticals 9(2016)2, 22
DOI: 10.3390/ph9020022
ISSN: 1424-8247

PET imaging evaluation of [¹⁸F]DBT-10, a novel radioligand specific to α₇ nicotinic acetylcholine receptors, in nonhuman primates

Hillmer, A. T.; Zheng, M.-Q.; Li, S.; Scheunemann, M.; Lin, S.-F.; et al. (13 authors)

European Journal of Nuclear Medicine and Molecular Imaging 43(2016)3, 537-547
Online First (2015) DOI: 10.1007/s00259-015-3209-0

A novel thermoregulatory role for PDE10A in mouse and human adipocytes

Hankir, M.; Kranz, M.; Gnad, T.; Wagner, S.; Deuther-Conrad, W.; et al. (16 authors)

EMBO Molecular Medicine 8(2016), 796-812
DOI: 10.15252/emmm.201506085
ISSN: 0021-9738

Development of highly potent phosphodiesterase 10A (PDE10A) inhibitors: Synthesis and in vitro evaluation of 1,8-dipyridyl- and 1-pyridinol-substituted imidazo[1,5-a]quinoxalines

Wagner, S.; Scheunemann, M.; Dipper, K.; Egerland, U.; Hoefgen, N.; et al. (7 authors)Steinbach, J.; Brust, P.

European Journal of Medicinal Chemistry 107(2016), 97-108
DOI: 10.1016/j.ejmech.2015.10.028

On the development of a novel non-peptidic ¹⁸F-labeled radiotracer for in vivo imaging of oxytocin receptors with positron emission tomography

Wenzel, B.; Mollitor, J.; Deuther-Conrad, W.; Kranz, M.; Dukic-Stefanovic, S.; et al. (13 authors)

Journal of Medicinal Chemistry 59(2016)5, 1800-1817
DOI: 10.1021/acs.jmedchem.5b01080
ISSN: 0022-2623

Jahre: 2020 2019 2018 2017 2016 2015 2014 2013 2012